Topics

Voyager Therapeutics Chief Operating Officer Matthew Ottmer Resigns

18:21 EST 14 Feb 2020 | Xconomy

Gene therapy developer Voyager Therapeutics (NASDAQ: VYGR) has lost its chief operating officer. Matthew Ottmer, who held the role since September 2017, resigned effective Feb. 12, according to a Friday securities filing. No reason was given. Though Ottmer has stepped down from his executive role, he will remain an at-will employee of Cambridge, MA-based Voyager […]

Original Article: Voyager Therapeutics Chief Operating Officer Matthew Ottmer Resigns

NEXT ARTICLE

More From BioPortfolio on "Voyager Therapeutics Chief Operating Officer Matthew Ottmer Resigns"

Quick Search

Relevant Topic

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...